Effects of Omega-3 Fatty Acid Supplementation on Lipid Levels in Endstage Renal Disease Patients

Journal of Renal Nutrition

Volumn 19, Issue 4, 2009, Pages 259-266

  Bowden, Rodney G ^a   Jitomir, Jean ^a   Wilson, Ronald L ^b   Gentile, Mindy ^c  

^a BAYLOR UNIVERSITY   (United States)

^b Central Texas Nephrology Associates   (United States)

^c Brazos Kidney Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; PLACEBO;

ADULT; AGED; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADULT; AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LIPIDS; MALE; MIDDLE AGED; PLACEBOS; RISK FACTORS;

ZEA MAYS;

EID: 67149141764     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2009.01.030     Document Type: Article

References (35)

1. Svensson M., Christensen J.H., Solling J., et al. The effect of n-3 fatty acids on plasma lipids and lipoproteins and blood pressure in patients with CRF. Am J Kidney Dis 44 (2004) 77-83
2. Gami A.S., Witt B.J., Howard D.E., et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49 (2007) 403-414
3. Banning M. The role of omega-3 fatty acids in the prevention of cardiac events. Br J Nutr 14 (2005) 503-508
4. Castro I.A., Barrosa L.P., and Sinnecker P. Functional foods for coronary heart disease risk reduction: a meta-analysis using a multivariate approach. Am J Clin Nutr 82 (2005) 32-40
5. Wang C., Harris W.S., Chung M., et al. N-3 fatty acids from fish or fish-oil supplements, but not α-linolenic acids, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 84 (2006) 5-17
6. Hugh P., Barrett R., and Watts G. Kinetic studies of lipoprotein in the metabolic syndrome including effects of nutrition interventions. Curr Opin Lipidol 14 (2003) 61-68
7. Foulon T., Richard M.J., Payen N., et al. Effects of fish oil fatty acids on plasma lipids and lipoproteins and oxidant ± antioxidant imbalance in healthy subjects. Scand J Clin Lab Invest 59 (1999) 239-248
8. Leigh-Firbank E.C., Minihane A.M., and Leake D.S. Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses. Br J Nutr 87 (2002) 435-445
9. National Institutes of Health. Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: third report (2002), US Government Printing Office, Washington, DC
10. Khajehdehi P. Lipid-lowering effect of polyunsaturated fatty acids in hemodialysis patients. J Ren Nutr 10 (2000) 191-195
11. Dyerberg J., Eckesen D.C., Anderson P.W., et al. Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk marker in healthy males. An 8 week dietary intervention study. Eur J Clin Nutr 58 (2004) 1062-1070
12. Hsu H., Lee Y., and Chen M. Effect of n-3 fatty acids on the composition and binding properties of lipoproteins in hypertriglyceridemic patients. Am J Clin Nutr 71 (2000) 28-35
13. Friedman A., and Moe S. Review of the effects of omega-3 supplementation in dialysis patients. Clin J Am Soc Nephrol 1 (2006) 182-192
14. Bucher H.C., Hengstler P., Schindler C., et al. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 112 (2002) 298-304
15. Demonty I., Chan Y.M., and Pelled D. Fish-oil esters of plant sterols improve the lipid profile of dyslipidemic subjects more than do fish-oil or sunflower oil esters of plant sterols. Am J Clin Nutr 84 (2006) 1534-1542
16. Harrison R.A., Sagara M., Rajpura A., et al. Can foods with added soya-protein or fish oil reduce risk factors for coronary artery disease? A factorial randomized controlled trial. Nutr Metab Cardiovasc Dis 14 (2004) 44-350
17. McKenney J.M., and Sica D. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia. Pharmacotherapy 27 (2007) 715-728
18. Saifullah A., Watkins B.A., Saha C., et al. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients-a pilot study. Nephrol Dial Transplant 22 (2007) 3561-3567
19. Jasti S., Siega-Riz A.M., Cogswell M.E., Hartzema A.G., and Bentley M.E. Pill count adherence to prenatal multivitamin/mineral supplement use among low-income women. J.Nutr 135 (2005) 1093-1101
20. Lee J., Kusek J., Greene P., et al. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) pilot study. Am J Hypertens 9 (1996) 719-725
21. Grundt H., Nilsen W.T., Hetland O., et al. Clinical outcome and atherothrombogenic risk profile after prolonged wash-out following longterm treatment with high doses of n-3 PUFAs in patients with an acute myocardial infarction. Clin Nutr 23 (2004) 491-500
22. Wu W.H., Lu S.C., Wang T.F., et al. Effects of docosahexaenoic acid supplementation on blood lipids, estrogen metabolism, and in vivo oxidative stress in postmenopausal vegetarian women. Eur J Clin Nutr 60 (2006) 386-392
23. Helland I.B., Saugstad O.D., Saarem K., et al. Supplementation of n-3 fatty acids during pregnancy and lactation reduces maternal plasma lipid levels and provides DHA to the infants. J Maternal Fetal Neonatal Med 19 (2006) 397-406
24. Galen P., Debree A., Mennen L., et al. Background and rationale of the Su.Fol.Om3 Study: double-blind randomized placebo controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acid on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries. J Nutr Health Aging 7 (2003) 428-435
25. Higgins S., Carroll Y.L., McCarthy S.N., et al. Susceptibility of LDL to oxidative modification in healthy volunteers supplemented with low doses of n-3 unsaturated fatty acids. Br J Nutr 85 (2001) 23-31
26. Malinowski J.M., and Metka K. Elevation of low-density lipoprotein cholesterol concentration with over-the-counter fish oil supplementation. Ann Pharmacother 41 (2007) 1296-1300
27. Bowden R.G., Hebert S., Wilson R., et al. Comparison of lipid measures and risk stratification among end-stage renal disease patients. J Nephrol 21 (2007) 212-218
28. Hamazaki K., Itomura M., Huan M., et al. N-3 long-chain FA decrease serum levels of TG and remnant-like particle-concentration in humans. Lipids 38 (2003) 353-358
29. Bowden R.G., Hebert S., Wilson R., et al. A cholesterol primer for health professionals. Cal J Health Promo 4 (2003) 12-21
30. Weber P., and Raederstorff D. Triglyceride-lowering effect of omega-3 LC-polyunsaturated fatty acids-a review. Nutr Metab Cardiovasc Dis 10 (2000) 28-37
31. Tulenko T.N., and Sumner A.E. The physiology of lipoproteins. J Nucl Cardiol 9 (2002) 638-649
32. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol 86 (2000) 943-949
33. Ginsberg H.N. New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism. Circulation 106 (2002) 2137-2142
34. Malloy M.J., and Kane J.P. A risk factor for atherosclerosis: triglyceride-rich lipoproteins. Adv Intern Med 47 (2001) 111-136
35. Mori T.A., and Beilin L.J. Omega-3 fatty acids and inflammation. Curr Atheroscler Rep 6 (2004) 461-467